Supply for oral cholera vaccine is expected to double this year as WHO approves a third supplier, South Korean company EuBiologics. The additional capacity could help nations fight outbreaks of the killer disease.
Supply for oral cholera vaccine is expected to double this year as WHO approves a third supplier, South Korean company EuBiologics. The additional capacity could help nations fight outbreaks of the killer disease.